Raab Michael
- SEC CIK
- 0001321402
In the past year, 10 open-market sale filings worth $2.57M and no purchases.
Current role at each company
- ARDX Ardelyx, Inc.President & CEOas of Aug 25, 2026
- FOLD Amicus Therapeutics, Inc.Directoras of Apr 27, 2026
- TPST Tempest Therapeutics, Inc.Directoras of Jan 28, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $2.57M
- 10 filings
- Net
- −$2.57M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Raab Michael as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ARDX Ardelyx, Inc.
President & CEO52 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 25, 2026 (view filing)7:07 PM ET | Aug 21 | 4 days | Raab MichaelPresident & CEO | SSale | −58.6K | $3.86 | −$225.9K | −3.5%1.62M after | 4 lots |
| Jul 17, 2026 (view filing)4:09 PM ET | Jul 15 | 2 days | Raab MichaelPresident & CEO | SSale | −41.7K | $5.06 | −$210.9K | −2.4%1.68M after | 10b5-1 |
| Jun 17, 2026 (view filing) | Jun 15 | 2 days | Raab MichaelPresident & CEO | SSale | −41.7K | $5.67 | −$236.2K | −2.4%1.70M after | 10b5-1 |
| May 22, 2026 (view filing) | May 21 | 1 day | Raab MichaelPresident & CEO | SSale | −54.7K | $6.27 | −$343.3K | −3.1%1.72M after | 4 lots |
| May 19, 2026 (view filing) | May 15 | 4 days | Raab MichaelPresident & CEO | SSale | −41.7K | $6.28 | −$261.7K | −2.3%1.77M after | 10b5-1 |
| Apr 17, 2026 (view filing) | Apr 15 | 2 days | Raab MichaelPresident & CEO | SSale | −41.7K | $6.29 | −$262.1K | −2.3%1.80M after | 10b5-1 |
| Mar 18, 2026 (view filing) | Mar 16 | 2 days | Raab MichaelPresident & CEO | SSale | −41.7K | $5.84 | −$243.3K | −2.2%1.82M after | 10b5-1 |
| Feb 25, 2026 (view filing) | Feb 24 | 1 day | Raab MichaelPresident & CEO | SSale | −41.7K | $6.26 | −$260.8K | −2.2%1.84M after | 10b5-1 |
| Feb 23, 2026 (view filing) | Feb 20 | 3 days | Raab MichaelPresident & CEO | SSale | −46.0K | $5.85 | −$269.0K | −2.4%1.86M after | 5 lots |
| Nov 25, 2025 (view filing) | Nov 21 | 4 days | Raab MichaelPresident & CEO | SSale | −46.9K | $5.54 | −$259.8K | −3.1%1.46M after |
FOLD Amicus Therapeutics, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 21, 2023 (view filing) | Mar 17 | 4 days | Raab MichaelDirector | SSale | −4.41K | $11.33 | −$49.9K | −6.8%60.0K after | |
| May 4, 2022 (view filing) | May 2 | 2 days | Raab MichaelDirector | SSale | −15.0K | $6.99 | −$104.8K | −29.0%36.7K after |